Skip to main content
Research use only (RUO) — laboratory and qualified research programs only
BLU
CJC-1295 + Ipamorelin (blend) research peptide vial by BluGen

GHRH + GHS blend (research)

CJC-1295 + Ipamorelin (blend)

Co-lyophilized blend in a single vial research peptide

Co-lyophilized GHRH analogue + selective GHS-R1a agonist research blend. Studied in vitro for GHRH-R / GHS-R co-stimulation work. Research use only.

$99.00

SKU BG-CJCIPA-0505

Vial size
  • Lot-specific CoA
  • Same-day dispatch Mon–Fri
  • Qualified buyers · RUO

Lab name and RUO acknowledgment are collected at checkout.

Lot documentation

Every shipment includes the lot-specific certificate of analysis — HPLC purity (≥99% typical), mass-spec identity, net peptide content, water content, and residual solvents.

Identity & specifications

Components
CJC-1295 (No DAC) + Ipamorelin
Ratio (mg : mg)
1 : 1 by mass (CoA reports actual)
Form
Co-lyophilized blend in a single vial
Component MW
3,367.95 / 711.86 g/mol
Appearance
White lyophilized powder
Purity (HPLC) per component
≥ 99%
Net peptide
Listed per component on CoA
Solubility
Soluble in bacteriostatic water

CJC-1295 + Ipamorelin blend in research

This blend co-lyophilizes a GHRH analogue (CJC-1295 No DAC / Modified GRF 1-29) with a selective GHS-R1a agonist (Ipamorelin) at equal mass. Published research has examined co-stimulation of GHRH-R and GHS-R as a reference paradigm for studying synergistic signaling at the somatotrope; this listing is structured so labs investigating that pathway can source both components as a single QC-traced unit.

Identity per component

Each lot ships with HPLC purity ≥99% reported separately for the GHRH analogue and the GHS peptide, and MS identity verification of each backbone. Net peptide content is reported per component on the CoA so molarity calculations remain accurate for split-channel assays.

Storage and handling

Hold sealed vials at -20 °C protected from light. Reconstitute the entire blend in bacteriostatic water; aliquot into single-use volumes and freeze. Because two peptides share a vial, do not draw partial-component aliquots without confirming the as-reconstituted concentration on the CoA.

Documentation

CoA covers per-component identity (MS), per-component purity (HPLC), as-blended mass ratio, and net peptide content per component. Batch records by lot are filed against the SKU.

Research guide

CJC-1295 + Ipamorelin (blend) research overview

CJC-1295 + Ipamorelin (blend) is listed as a research-use-only material for qualified laboratory programs. This page connects the product listing with identity fields, storage context, CoA review, and long-form research resources so procurement and QA reviewers can evaluate the SKU without relying on a thin commerce page.

The catalog classifies this material as GHRH + GHS blend (research), which helps labs compare it with adjacent research peptides, organize internal inventory, and build study-specific reference groups.

Key identity fields

Components
CJC-1295 (No DAC) + Ipamorelin
Ratio (mg : mg)
1 : 1 by mass (CoA reports actual)
Form
Co-lyophilized blend in a single vial
Component MW
3,367.95 / 711.86 g/mol
Appearance
White lyophilized powder
Purity (HPLC) per component
≥ 99%

Storage and handling context

For long-tail stability searches, CJC-1295 + Ipamorelin (blend) should be evaluated in the context of lyophilized storage, reconstitution buffer choice, aliquot planning, freeze-thaw limits, and lot-specific CoA conditions. Always follow institutional SOPs and the documentation attached to the received lot.

Mechanism context

CJC-1295 + Ipamorelin (blend) should be described through published model-system language: receptor family, pathway context, assay controls, concentration planning, and lot traceability. Avoid transferring assumptions from adjacent peptides without a documented comparison protocol.

Search intent covered

  • CJC-1295 + Ipamorelin (blend) storage and stability
  • CJC-1295 + Ipamorelin (blend) CoA and identity
  • CJC-1295 + Ipamorelin (blend) mechanism research
  • CJC-1295 + Ipamorelin (blend) comparison resources

Product FAQ

Is CJC-1295 + Ipamorelin (blend) intended for clinical programs?

No. BluGen listings are research use only (RUO) materials for qualified laboratory programs, not clinical, diagnostic, therapeutic, veterinary, food, drug, or cosmetic use.

What documentation is available for CJC-1295 + Ipamorelin (blend)?

Lot-level documentation may include CoA, HPLC purity, MS identity confirmation, net peptide content, and batch records where available for the SKU and lot.

How should lyophilized CJC-1295 + Ipamorelin (blend) be stored?

Store sealed lyophilized vials cold, dry, and protected from light unless the lot CoA or institutional SOP specifies another condition. Reconstituted material should be aliquoted according to the lab protocol.

Where can I learn more about CJC-1295 + Ipamorelin (blend) research context?

See the BluGen research guide for mechanism context, stability notes, storage considerations, and related peptide comparisons: https://getblugen.com/research/research-guide-cjc-1295-plus-ipamorelin/

What is the research category for CJC-1295 + Ipamorelin (blend)?

CJC-1295 + Ipamorelin (blend) is categorized as GHRH + GHS blend (research) for catalog organization, internal linking, and related research comparisons.

What sequence is listed for CJC-1295 + Ipamorelin (blend)?

Sequence identity should be verified against the lot-specific CoA and product identity table before release into a research workflow.

What molecular weight is listed for CJC-1295 + Ipamorelin (blend)?

Molecular weight should be verified from the product identity table and lot CoA before concentration calculations.

Does CJC-1295 + Ipamorelin (blend) require cold storage?

Most lyophilized research peptides are stored cold, dry, sealed, and protected from light unless the lot CoA or institutional SOP states otherwise.

How should reconstituted CJC-1295 + Ipamorelin (blend) be handled?

Reconstituted research stocks should be labeled with SKU, lot, solvent, concentration, date, and technician initials, then aliquoted according to the lab protocol to limit freeze-thaw history.

Can lots of CJC-1295 + Ipamorelin (blend) be mixed together?

Avoid mixing lots unless a written protocol requires it. Mixed-lot stocks reduce traceability and make CoA review more difficult.

What purity documentation matters for CJC-1295 + Ipamorelin (blend)?

HPLC purity, MS identity, net peptide content, moisture or residual summaries where available, and lot number alignment are the core documentation checks.

What does net peptide content mean for CJC-1295 + Ipamorelin (blend)?

Net peptide content accounts for peptide mass apart from water and counter-ion contribution. It is important for molarity calculations in laboratory records.

What should procurement review before ordering CJC-1295 + Ipamorelin (blend)?

Procurement should review SKU, vial size, lot documentation path, RUO status, storage requirements, shipping expectations, and any internal approval requirements.

How should CJC-1295 + Ipamorelin (blend) be cited in a method record?

Record supplier, SKU, lot number, CoA document ID, reconstitution solvent, stock concentration, storage condition, and date prepared.

What are common related resources for CJC-1295 + Ipamorelin (blend)?

Related resources include the peptide storage guide, reconstitution guide, CoA reading guide, purity guide, and any comparison articles linked from the product page.

Why does BluGen link CJC-1295 + Ipamorelin (blend) to research articles?

Internal article links help buyers evaluate identity, storage, documentation, and research context without relying on a thin product listing.

What should be done if CJC-1295 + Ipamorelin (blend) documentation is incomplete?

Hold the lot in review and request the missing CoA or batch documentation before releasing the material into an internal research workflow.

Is CJC-1295 + Ipamorelin (blend) content on BluGen medical advice?

No. BluGen content is laboratory procurement and research documentation content for RUO materials only.

Related research resources

Reference path

Research use only (RUO)

This material is sold for laboratory research purposes only. It is not for clinical, diagnostic, therapeutic, or veterinary application, and not for food, drug, or cosmetic use where restricted.

Cited in research library

CJC-1295 + Ipamorelin (blend)